"Nobel Prize in medicine" announced that GlaxoSmithKline, spark and Abbott are on the list
-
Last Update: 2019-10-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, the Galen foundation announced the list of Prix Galen awards in 2019 The Galen prize, known as the "Nobel Prize in medicine", is recognized as the highest honor in medicine and biomedical industry It honors outstanding scientific innovation for improving human health The Galen prize is selected by a jury of Nobel laureates, including the best pharmaceutical product, the best biotechnology product and the best medical technology The winners in 2019 are: Shinglix is a herpes zoster vaccine developed by GSK, which was approved by FDA in 2017 Herpes zoster, commonly known as "banded waist dragon", is caused by reactivation of varicella zoster virus (VZV) The initial symptom of varicella zoster virus infection is varicella Although the symptoms of the patient will disappear, the virus will lurk in the nerve cells in the spinal cord and ganglia of the patient These latent viruses may be reactivated years later, with blisters in the chest, abdomen, or face, accompanied by unbearable pain The disease is more common in the elderly, and a safe and effective vaccine is expected to protect them from herpes zoster infection Shritrix is a kind of inactivated recombinant vaccine In clinical trials, its effective rate of preventing herpes zoster is more than 90% The recombinant vaccine was also approved by China's National Drug Administration (nmpa) in May this year and will be available in China Luxturna is the first gene therapy approved in the United States to treat specific genetic diseases It was approved by FDA in December 2017 to treat patients with hereditary retinal dystrophy carrying RPE65 gene mutation Because of different types of gene mutations, the vision of patients with hereditary retinal dystrophy gradually decreases Novartis has acquired its exclusive rights outside the United States Luxturna inserted the transgenic gene expressing normal RPE65 enzyme into adeno-associated virus (AAV) vector and injected it into the retina cells of patients by subretinal injection Only one treatment is needed This gene therapy can make retinal cells produce normal RPE65 protein and significantly improve the vision of patients When luxturna was approved, Dr Peter marks, head of FDA's Center for biological evaluation and research, once said, "luxturna's approval opened a new door to the infinite potential of gene therapy." Since then, a number of large pharmaceutical companies have been in the field of gene therapy, and zolgensma, a Novartis gene therapy for spinal muscular atrophy (SMA), has also been approved by the FDA this year Spark therapeutics, the star company that developed luxturna, is expected to become a Roche member next year For diabetic patients, monitoring their blood glucose level is one of the key to managing diabetes The usual blood glucose detection system needs to let patients take blood from their fingers, which not only brings pain to patients, but also inconvenience to patients who need frequent blood glucose detection Abbott's instant scanning glucose detection system attaches a small (one dollar coin size) circular sensor on the upper arm of the patient, so that the patient can read the glucose reading just by using a hand-held scanner to quickly scan the sensor The sensor can automatically measure glucose within 14 days, avoiding the pain and trouble of daily needle "The winners in 2019 reflect the vision of the Galen foundation to improve human health, while highlighting the dedication of scientists and researchers to improve human health and fight against disease," said Mr Bruno Cohen, chairman of the Galen foundation "The committee is inspired by the dedication of the winners and selected people to patient care, and we are honored to recognize their achievements " We congratulate all the winners and wish these innovative products to benefit more patients reference material: [1] The Galien Foundation Honors 2019 Prix Galien Award Recipients Retrieved October 25, 2019, from https:// [2] The Galien Foundation Retrieved October 25, 2019, from http:// [3] ABBOTT'S FREESTYLE® LIBRE 14 DAY FLASH GLUCOSE MONITORING SYSTEM NOW APPROVED IN U.S Retrieved October 25, 2019, from https://abbott.mediaroom.com/2018-07-27-Abbotts-FreeStyle-R-Libre-14-Day-Flash-Glucose-Monitoring-System-Now-Approved-in-U-S A kind of
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.